Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke

Stroke

Volumn 38, Issue 1, 2007, Pages 90-95

  Millan, Mónica ^a   Sobrino, Tomás ^b   Castellanos, Mar ^c   Nombela, Florentino ^d   Arenillas, Juan F ^a   Riva, Elena ^c   Cristobo, Iván ^b   García, María M ^c   Vivancos, José ^d   Serena, Joaquín ^c   Moro, María A ^e   Castillo, José ^b   Dávalos, Antonio ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e SCHOOL OF MEDICINE   (Spain)

Author keywords

Ferritin; Iron overload; Ischemic stroke; Outcome; Oxidative stress; Thrombolysis

Indexed keywords

DISUFENTON SODIUM; FERRITIN; IRON; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; HUMAN; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RATING SCALE; STROKE; TREATMENT OUTCOME;

AGED; BRAIN; BRAIN EDEMA; CAUSALITY; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; FEMALE; FERRITINS; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33845934122     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000251798.25803.e0     Document Type: Article

References (24)

1. Alexandrov AV, Hall CE, Labiche LA, Wojner AW, Grotta JC. Ischemic stunning of the brain. Early recanalization without immediate clinical improvement in acute ischemic stroke. Stroke. 2004;35:449-452.
2. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD. Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke. 2001;32:661-668.
3. Kidwell CS, Saver JL, Starkman S, Duckwiler G, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Gobin YP, Vinuela F, Alger JR. Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol. 2002;52:698-703.
4. Lo EH, Broderick JP, Moskowitz MA. tPA and proteolysis in the neurovascular unit. Stroke. 2004;35:354-356.
5. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo E. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke. 2005;36:1954-1959.
6. Aoki T, Sumii T, Mori T, Wang X, Lo EH. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury. Mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke. 2002;33:2711-2717.
7. Gürsoy-Özdemir Y, Can A, Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke. 2004;35:1449-1453.
8. Selim MH, Ratan RR. The role of iron neurotoxicity in ischemic stroke. Ageing Research Reviews. 2004;3:345-353.
9. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med. 1992;12:417-427.
10. Castellanos M, Puig N, Carbonell T, Castillo J, Martínez JM, Rama R, Dávalos A. Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats. Brain Res. 2002;952:1-6.
11. Patt A, Horesh IR, Berger EM, Harken AH, Repine JE. Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains. J Pediatr Surg. 1990;25:224-228.
12. Davis S, Helfaer MA, Traystman RJ, Hum PD. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke. 1997;28:198-205.
13. Davalos A, Fernandez-Real JM, Ricart W, Soler S, Molins A, Planas E, Genis D. Iron-related brain damage in acute ischemic stroke. Stroke. 1994;25:1543-1546.
14. Davalos A, Castillo J, Marrugat J, Fernández-Real JM, Armengou A, Cacabelos P. Rama R. Body iron stores and early neurological deterioration in acute cerebral infarction. Neurology. 2000;54:1568-1574.
15. Erdemoglu AK, Ozbakir S. Serum ferritin levels and early prognosis of stroke. Eur J Neurol. 2002;9:633-637.
16. Herbert V, Jayatilleke E, Shaw S, Rosman AS, Giardina P, Grady RW, Bowman B, Gunter EW. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells. 1997;15:291-296.
17. Walters GO, Miller FM, Worwood M. Serum ferritin concentrations and iron stores in normal subjects. J Clin Pathol. 1973;26:770-772.
18. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW; for the Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for Acute Ischemic Stroke. N Engl J Med. 2005;354:588-600.
19. Connor JR, Menzies SL, St. Martin SM, Mufson EJ. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res. 1990;27:595-611.
20. Qi Y, Jamindar M, Dawson G. Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J Neurochem. 1995;64:2458-2464.
21. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM. Ferritin and the response to oxidative stress. Biochem J. 2001;357:241-247.
22. Sánchez M, Villa M, Ingelmo M, Sanz C, Bruguera M, Ascaso C, Oliva R. Population screening for hemochromatosis: a study in 5370 Spanish blood donors. J Hepatol. 2003;38:745-750.
23. Armengou A, Dávalos A. Serum ferritin concentrations are not modified in the acute phase of ischemic stroke. Stroke. 1998;29:258-260.
24. Asahi M, Asahi K, Wang X, Lo EH. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2000;20:452-457.